Ensign Peak Advisors Inc Grows Stock Position in agilon health, inc. (NYSE:AGL)

Ensign Peak Advisors Inc increased its holdings in agilon health, inc. (NYSE:AGL) by 43.5% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 140,937 shares of the company’s stock after buying an additional 42,750 shares during the period. Ensign Peak Advisors Inc’s holdings in agilon health were worth $922,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in the business. Scotia Capital Inc. boosted its position in shares of agilon health by 1.3% in the 4th quarter. Scotia Capital Inc. now owns 132,576 shares of the company’s stock worth $1,664,000 after buying an additional 1,741 shares in the last quarter. Arizona State Retirement System boosted its position in shares of agilon health by 2.5% in the 2nd quarter. Arizona State Retirement System now owns 85,989 shares of the company’s stock worth $562,000 after buying an additional 2,070 shares in the last quarter. Nomura Asset Management Co. Ltd. boosted its position in shares of agilon health by 31.5% in the 4th quarter. Nomura Asset Management Co. Ltd. now owns 8,969 shares of the company’s stock worth $113,000 after buying an additional 2,149 shares in the last quarter. Swiss National Bank boosted its position in shares of agilon health by 0.6% in the 1st quarter. Swiss National Bank now owns 602,800 shares of the company’s stock worth $3,677,000 after buying an additional 3,400 shares in the last quarter. Finally, J.Safra Asset Management Corp boosted its position in shares of agilon health by 626.1% in the 2nd quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company’s stock worth $27,000 after buying an additional 3,625 shares in the last quarter.

Analysts Set New Price Targets

AGL has been the subject of several analyst reports. Deutsche Bank Aktiengesellschaft cut their target price on shares of agilon health from $5.00 to $4.00 and set a “hold” rating for the company in a research note on Friday, August 9th. Royal Bank of Canada reissued an “outperform” rating and issued a $8.00 target price on shares of agilon health in a research note on Wednesday, August 7th. Evercore ISI boosted their target price on shares of agilon health from $5.50 to $7.00 and gave the company an “in-line” rating in a research note on Tuesday, July 9th. Finally, Benchmark reaffirmed a “buy” rating and set a $9.00 price objective on shares of agilon health in a research note on Thursday, August 8th. One equities research analyst has rated the stock with a sell rating, fourteen have assigned a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $8.57.

agilon health Stock Up 0.3 %

AGL opened at $3.74 on Friday. The firm has a 50 day moving average price of $4.83 and a 200 day moving average price of $5.45. The company has a market cap of $1.54 billion, a PE ratio of -5.34 and a beta of 0.54. agilon health, inc. has a 1 year low of $3.07 and a 1 year high of $20.37. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.36 and a current ratio of 1.36.

agilon health (NYSE:AGL) last released its quarterly earnings results on Tuesday, August 6th. The company reported ($0.07) earnings per share for the quarter, hitting analysts’ consensus estimates of ($0.07). The firm had revenue of $1.48 billion during the quarter, compared to analysts’ expectations of $1.56 billion. agilon health had a negative return on equity of 29.91% and a negative net margin of 5.57%. agilon health’s quarterly revenue was up 38.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned ($0.04) EPS. Sell-side analysts expect that agilon health, inc. will post -0.32 earnings per share for the current year.

Insiders Place Their Bets

In related news, CEO Steven Sell purchased 20,000 shares of the firm’s stock in a transaction on Thursday, September 12th. The stock was purchased at an average price of $3.36 per share, for a total transaction of $67,200.00. Following the acquisition, the chief executive officer now directly owns 67,590 shares in the company, valued at $227,102.40. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 3.20% of the stock is owned by company insiders.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.